Chu Hsien-I Memorial Hospital, Tianjin Medical University - China
AUTHOR PROFILE
ORCID
EARLY ACADEMIC PURSUITS
Liming Chen embarked on his academic journey with a strong focus on endocrinology and metabolism. As evidenced by his editorial roles in prestigious journals such as the "International Journal of Endocrinology and Metabolism" and the "Chinese Journal of Diabetes Mellitus," Chen demonstrated an early commitment to advancing knowledge in these fields.
PROFESSIONAL ENDEAVORS
Throughout his career, Liming Chen has held various editorial appointments and leadership positions, including the Vice Chairman of the Chinese Diabetes Association and Chairman of the Tianjin Diabetes Association. His extensive involvement in professional societies underscores his dedication to fostering collaboration and innovation in metabolic research.
Chen's contributions span a wide range of metabolic-related diseases, including diabetes, nonalcoholic fatty liver disease, and obesity. His research efforts have delved into diverse topics such as the application of Tripterygium Glycosides in Diabetic Nephropathy and the mechanism of action of SGLT2 inhibitors in diabetes and its complications.
IMPACT AND INFLUENCE
Liming Chen's work has left a significant impact on the field of endocrinology and metabolism, as evidenced by his numerous publications in high-impact journals and his editorial roles in leading scientific publications. His research has contributed to advancing our understanding of metabolic diseases and exploring endocrine and metabolic disease novel therapeutic avenues.
ACADEMIC CITATIONS
Chen's research has garnered significant attention within the scientific community, as reflected by the substantial citation index of his publications. His work on topics such as the attenuation of myocardial oxidative stress and fibrosis in diabetic mice heart and the endocrine and metabolic disease protective effects of pancreatic kallikrein against diabetic retinopathy has been cited extensively.
LEGACY AND FUTURE CONTRIBUTIONS
Liming Chen's legacy in the field of metabolic research is characterized by his prolific publications, editorial leadership, and active involvement in professional societies. Looking ahead, Chen's future contributions are poised to further advance our understanding of metabolic diseases and pave the way for innovative therapeutic interventions.
NOTABLE PUBLICATIONS
RASSF4 attenuates metabolic dysfunction-associated steatotic liver disease progression via Hippo signaling 2024
The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian 2023
Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management 2023
Fenofibrate Attenuates Renal Tubular Cell Apoptosis by Up-Regulating MCAD in Diabetic Kidney Disease 2023
ChREBP-β/TXNIP aggravates frucose-induced renal injury through triggering ferroptosis of renal tubular epithelial cells 2023